Compare FMC Corp (FMC) vs Vanguard Short Term Corporate Bond ETF (VCSH) Price & Performance

FMC Corporation (FMC) trades at $11.61, up 8.3% today, but remains in a challenging fundamental position with a net income margin of -72.93% and negative ROE of -80.78% for 2025. The company is actively restructuring, securing a $400 million minority investment from Tessenderlo Group and planning a $114 million property sale to reduce its $3.03 billion long-term debt. Technical indicators are bearish, with the stock trading near key support at $11. Recent news highlights progress on its new herbicide, rimisoxafen, including a regulatory submission to the EPA and a partnership with Corteva.

The outlook is cautious. While aggressive debt reduction and new product pipelines offer potential, deep losses and declining revenue pose significant risks. The analyst consensus is mixed (47.6% Buy, 50% Hold) with a $16 price target, suggesting modest upside if turnaround efforts succeed, but high execution risk remains the primary concern for investors.

VCSH, the Vanguard Short-Term Corporate Bond ETF, trades at $78.715 with a slight 0.15% daily gain. Technical indicators show a bearish trend with moving averages signaling caution, while oscillators remain neutral. The ETF focuses on investment-grade corporate debt, offering a competitive yield and low expense ratio of 0.03% as highlighted by The Motley Fool on July 13, 2026. Recent institutional activity includes mixed stake adjustments, with Caldwell Trust boosting its position by 1,276.3% in Q4 2025 per SEC filings.

The outlook for VCSH is stable, benefiting from its short-duration bond focus amid a higher-rate environment, though the bearish technical trend and potential interest rate volatility pose risks. Its low costs and monthly dividends appeal to income-focused investors, but competition from treasury ETFs and tax-exempt alternatives requires careful consideration of individual tax situations and risk tolerance.